Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Taubert

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Biomedicines|April 3, 2021
Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASHKatharina Luise Hupa-Breier, Janine Dywicki, Björn Hartleben, et al.
Nature|August 10, 2007
An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymusMatthieu Giraud, Richard Taubert, Claire Vandiedonck, et al.
Abdominal Radiology (New York)|November 5, 2024
Percutaneous transhepatic biliary drainage in patients with cholestasis following liver transplantationThorben Pape, Tabea von Garrel, Anna M Hunkemöller, et al.
Journal of Clinical Apheresis|June 26, 2020
Therapeutic plasma exchange in acute on chronic liver failureKlaus Stahl, Markus Busch, Jan Fuge, et al.
Plos One|November 2, 2022
Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19Theresa Kirchner, Sophia Heinrich, Agnes Bonifacius, et al.
Plos One|January 28, 2014
Increased HEV seroprevalence in patients with autoimmune hepatitisSven Pischke, Anett Gisa, Pothakamuri Venkata Suneetha, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 12, 2025
Liver transplantation indications and strategies in polycystic liver disease: A european surveyRenée Duijzer, Ian P J Alwayn, Flaminia Ferri, et al.
Journal of Hepatology|September 1, 2024
Identification and functional validation of miR-190b-5p and miR-296-3p as novel therapeutic attenuators of liver fibrosisJovana Markovic, Ruomeng Li, Rajendra Khanal, et al.
Journal of Autoimmunity|May 14, 2018
Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in miceEdith Hintermann, Monika Bayer, Clara Benedetta Conti, et al.
Clinical Transplantation|May 19, 2026
A Retrospective Multicenter Study Identifies a Similar Overall Survival of Patients After Liver Transplantation With Incidental Cholangiocarcinoma Compared to Hepatocellular CarcinomaSophia Heinrich, Alejandro Campos-Murguia, Angelina Mensah, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Biomedicines|April 3, 2021
Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASHKatharina Luise Hupa-Breier, Janine Dywicki, Björn Hartleben, et al.
Nature|August 10, 2007
An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymusMatthieu Giraud, Richard Taubert, Claire Vandiedonck, et al.
Abdominal Radiology (New York)|November 5, 2024
Percutaneous transhepatic biliary drainage in patients with cholestasis following liver transplantationThorben Pape, Tabea von Garrel, Anna M Hunkemöller, et al.
Journal of Clinical Apheresis|June 26, 2020
Therapeutic plasma exchange in acute on chronic liver failureKlaus Stahl, Markus Busch, Jan Fuge, et al.
Plos One|November 2, 2022
Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19Theresa Kirchner, Sophia Heinrich, Agnes Bonifacius, et al.
Plos One|January 28, 2014
Increased HEV seroprevalence in patients with autoimmune hepatitisSven Pischke, Anett Gisa, Pothakamuri Venkata Suneetha, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 12, 2025
Liver transplantation indications and strategies in polycystic liver disease: A european surveyRenée Duijzer, Ian P J Alwayn, Flaminia Ferri, et al.
Journal of Hepatology|September 1, 2024
Identification and functional validation of miR-190b-5p and miR-296-3p as novel therapeutic attenuators of liver fibrosisJovana Markovic, Ruomeng Li, Rajendra Khanal, et al.
Journal of Autoimmunity|May 14, 2018
Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in miceEdith Hintermann, Monika Bayer, Clara Benedetta Conti, et al.
Clinical Transplantation|May 19, 2026
A Retrospective Multicenter Study Identifies a Similar Overall Survival of Patients After Liver Transplantation With Incidental Cholangiocarcinoma Compared to Hepatocellular CarcinomaSophia Heinrich, Alejandro Campos-Murguia, Angelina Mensah, et al.
Pageof 12